Price: $393.75 Main Volume
Meet The Author
A guide through the minefield of court decisions that have systematically eroded the scope and validity of patents.
This treatise helps practitioners draft the broadest possible patent by synthesizing and applying lessons from the case law to sustain a validity challenge. It provides in-depth discussions on pitfalls in claim drafting; dangers of means plus-function clauses in claims; strategies to target direct infringers; the scope of enablement trends; instructions on how to “Festo-proof” a patent application; and more.
The Third Edition is revised to:
Update discussions based on evolving post-AIA (Leahy-Smith America Invents Act) case law
Analyze evolving case law under 35 U.S.C. §101 and the U.S. Supreme Court’s Alice Corp. decision
Incorporate Supreme Court decisions on the PTAB’s authority and scope of review (Oil States Energy Services, LLC v. Greene’s Energy Group, LLC, confirming Congress’s authority to create the PTAB trial system, and SAS Institute Inc. v. Iancu. rejecting the USPTO’s argument that its practice of partial institutions was unreviewable)
Address 2018 USPTO guidance on recent subject matter eligibility decisions
The Third Edition also focuses on significant court decisions relating to patent law, including:
In Travel Sentry, Inc. v. Tropp, the Federal Circuit noted “the importance of correctly identifying the relevant ‘activity’ or ‘benefit’ that is being conditioned upon the performance of one or more claim steps”
An updated discussion on double patenting issues in chemical cases, including discussion of Gilead Sciences, Inc. v. Natco Pharma Ltd., where the Federal Circuit clarified that claims in a later-expiring patent that are obvious over an earlier-expiring patent must be terminally disclaimed or cancelled, regardless of which application was filed first, at least under modern rules of calculating patent term
In the context of a biotechnology invention, the Supreme Court clarified the meaning of a “substantial portion” of the invention in Life Technologies Corp. v. Promega Corp.
In Helsinn Healthcare S.A. v. Teva Pharms. USA, Inc., the Federal Circuit interpreted the “on-sale bar” provisions of the post-AIA version of 35 U.S.C. §102(b); the Supreme Court has granted cert.
In re Janssen Biotech, Inc., the Federal Circuit held that an attempt to re-designate a patent issued on a CIP application as a divisional application during reexamination was insufficient to provide the issued patent the benefit of the Section 121 safe harbor
The Risk of Inadvertent Misuse of Information Disclosed in Discovery to a Litigator who Performs Other Functions for her Client
An extensive discussion of the three step process for determining whether litigators who also prosecute patent applications should be barred from access to the opposing party’s highly confidential information
Expanded and updated discussions of harmonization of different national approaches to patents, the Unified Patent Court in Europe, and forum shopping when litigating in Europe
Summary of Contents
Chapter 1. The State of the Law of Claim Construction and Infringement
Chapter 2. Pitfalls in Patent Drafting
Chapter 3. Drafting the Winning Patent
Chapter 4. Continued Prosecution of the Patent
Chapter 5. Mechanical Patents
Chapter 6. Electrical Patents
Chapter 7. Software, E-Commerce, Internet, and Business Method Patents
Chapter 8. Chemical and Pharmaceutical Patents
Chapter 9. Biotechnology Patents
Chapter 10. Design Patents
Chapter 11. Combining Prosecution With Other Forms of Representation
Chapter 12. Drafting U.S. Patents With a View Toward Europe
Chapter 13. Validity Trials at the Patent Trial and Appeal Board
I highly recommend BNA’s new book, Drafting Patents for Litigation and Licensing. I find it to be an excellent resource for patent practitioners who prepare and prosecute patent applications from the perspective of how patents issuing from their applications will be litigated or licensed. This remarkable book comprehensively provides practical guidance to its readers utilizing real-world litigation examples covering a broad spectrum of technologies for drafting high quality patent applications that can be filed in both the United States and Europe.
Partner, Oblon, Spivak, McClelland, Maier & Neustadt, PC, Director of the Intellectual Law Program at the George Mason School of Law, Former Deputy Commissioner for Patent Examination Policy with the U.S. Patent and Trademark Office
Drafting Patents for Litigation and Licensing is an excellent book for anyone involved in the practice of writing patent applications, preparing patent non-infringement and invalidity opinions, or litigating patents. For business attorneys who already have a general understanding of patent law and desire to learn more, this book will serve as a good reference. The authors selected to write each chapter clearly know their subjects and do an excellent job of presenting the material. The book is well crafted to assist those in the practice of drafting, litigating, or licensing patents to assist their clients in assessing the strengths and weaknesses of a patent.
Patent Attorney, Author, Partner with Swanson and Bratschun, LLC, Denver, CO
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)